𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dietary phytoestrogen intake and premenopausal breast cancer risk in a German case-control study

✍ Scribed by Jakob Linseisen; Regina Piller; Silke Hermann; Jenny Chang-Claude

Publisher
John Wiley and Sons
Year
2004
Tongue
French
Weight
96 KB
Volume
110
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

A diet high in isoflavonoids (soy) is associated with lower breast cancer risk in Asian populations. Due to the low soy intake, dietary lignans may be the more important phytoestrogen class in Western populations. We used a population‐based case‐control study of breast cancer by age 50 in southern Germany to evaluate the association between dietary intake of different phytoestrogens and premenopausal breast cancer risk. Dietary information was collected from 278 premenopausal cases and 666 age‐matched controls, using a validated FFQ. Using multivariate logistic regression, the highest vs. lowest intake quartiles of daidzein and genistein yielded significantly reduced ORs (95% CI) for breast cancer risk of 0.62 (0.40–0.95) and 0.47 (0.29–0.74), respectively. The protective effects of daidzein and genistein were found only for hormone receptor‐positive tumors. High intake of other isoflavonoids, e.g., formononetin and biochanin A, as well as the sum of isoflavonoids were not associated with a decrease in risk. Breast cancer risk significantly decreased with a high intake of the plant lignan matairesinol (OR = 0.58, 95% CI 0.37–0.94) but not secoisolariciresinol or the sum of plant lignans. However, both estimated mammalian lignans, enterodiol and enterolactone, were inversely associated with breast cancer risk, with ORs (95% CI) of 0.61 (0.39–0.98) and 0.57 (0.35–0.92), respectively. No effect was found for total phytoestrogen intake. Our results suggest an important role of dietary intake of daidzein and genistein, despite low levels, as well as of matairesinol and mammalian lignans to reduce premenopausal breast cancer risk in this study population. © 2004 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Plasma 25-hydroxyvitamin D and premenopa
Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a German case-control study
✍ Sascha Abbas; Jenny Chang-Claude; Jakob Linseisen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 112 KB 👁 1 views

## Abstract Laboratory and epidemiological data have linked vitamin D to breast cancer prevention. Beside dietary intake, endogenous production of vitamin D substantially contributes to a subject's vitamin D status. Most studies, however, have assessed dietary intake only. Although differential eff

A case–control study on the dietary inta
A case–control study on the dietary intake of mushrooms and breast cancer risk among Korean women
✍ Seo Ah Hong; Kirang Kim; Seok-Jin Nam; Gu Kong; Mi Kyung Kim 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 78 KB 👁 2 views

## Abstract To evaluate the association between dietary mushroom intake and breast cancer risk, a total of 362 women between the ages of 30 and 65 years who were histologically confirmed to have breast cancer were matched to controls by age (±2 years) and menopausal status. Mushroom intake was meas

Dietary acrylamide intake and risk of es
Dietary acrylamide intake and risk of esophageal cancer in a population-based case-control study in Sweden
✍ Yulan Lin; Jesper Lagergren; Yunxia Lu 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 130 KB 👁 1 views

## Abstract Acrylamide is a potential carcinogen, which commonly occurs in some food items. The relation between acrylamide and esophageal cancer deserves attention. In a Swedish nationwide, population‐based case‐control study, data were collected on diet among other variables in 1995–1997 through

Dietary flavonoid intake and lung cancer
Dietary flavonoid intake and lung cancer—A population-based case-control study
✍ Yan Cui; Hal Morgenstern; Sander Greenland; Donald P. Tashkin; Jenny T. Mao; Lin 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 1 views

## Abstract ## BACKGROUND Laboratory studies suggest that flavonoids are antimutagenic and anticarcinogenic. To investigate the associations between commonly consumed flavonoid compounds and lung cancer, the authors conducted a population‐based case–control study of 558 lung cancer cases and a gro